AstraZeneca Fails to Soothe EU Ire Over Vaccine-Delivery Delays

The transcript discusses the European Union's growing frustration with Astra Zeneca over vaccine delivery delays. The EU, having invested €2.7 billion in vaccine development, is considering legal actions and potential export bans to ensure contracts are honored. The EU's health commissioner expressed unusual anger, emphasizing the need for transparency in vaccine production and distribution, as upfront payments were made to avoid such issues.

How much has the European Union invested in vaccine development according to the text?

What actions is the European Union considering in response to Astra Zeneca's delivery issues?

What potential legal actions are being discussed in relation to Astra Zeneca's vaccine deliveries?

What unusual behavior did the European Health Commissioner exhibit in her statements?

What is the European Union's concern regarding the vaccines produced?